MK7339-003

Efficacy and Safety of Olaparib, Olaparib + Bevacizumab Compared to Bevacizumab + 5-Fluorouracil (FU)

A221805

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

GI005 (Suspended)

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery (Suspended)

S1820

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

A021703

Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (SOLARIS)

WF-1806

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

ES2018-01 (Suspended)

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (Suspended)

GI004

Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer

A021502

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

GI002 (Suspended)

Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (Suspended)

Search Results

Search Again